Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
NCT01325207
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
RADIATION:
Trastuzumab
Sponsor
Northwestern University